Showing results (521-530 of 4,870) with videos related to
Sort By:
Pageof 487
Urologic Oncology|October 7, 2011
Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcomeJulia Heinzelbecker, Kai-Michael Kempf, Katrin Kurz, et al.Urologic Oncology|June 14, 2011
Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: a pilot studyYao Zhu, Xiao-Yan Zhou, Xu-Dong Yao, et al.Urologic Oncology|June 14, 2011
Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgeryAlessandro Sciarra, Susanna Cattarino, Alessandro Gentilucci, et al.Urologic Oncology|August 2, 2011
Serum carcino-embryonic antigen (CEA) and its possible use as tumor marker for secondary tumors in urinary intestinal reservoirsAndreas Loeser, Michael Neumann, Arkardius Kocot, et al.Urologic Oncology|August 2, 2011
Manserin as a novel histochemical neuroendocrine marker in prostate cancerKouhei Nishikawa, Norihito Soga, Kenichiro Ishii, et al.Urologic Oncology|August 2, 2011
Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosisAnna Vinarskaja, Wolfgang A Schulz, Marc Ingenwerth, et al.Urologic Oncology|October 22, 2011
Intravenous therapies for castration-resistant prostate cancer: toxicities and adverse eventsEric A Singer, Ramaprasad SrinivasanUrologic Oncology|September 20, 2011
Is the diagnostic yield of prostate needle biopsies affected by prostate volume?Dan Leibovici, Yaniv Shilo, Orit Raz, et al.Urologic Oncology|September 30, 2011
Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era?Nobuo Shinohara, Takashige Abe, Tango Mochizuki, et al.Urologic Oncology|August 27, 2011
Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progressionAfrodite Athanasopoulou, Panagiotis Aroukatos, Dimitrios Nakas, et al.Pageof 487